Another nitric oxide donor, RRx-001, is also capable of inducing NO production under hypoxic conditions and has demonstrated synergistic tumor cell cytotoxicity with radiation therapy by inhibiting the IκB kinase (IKK) complex, the master kinase for NF-κB activation [171,172,173]. The gene discussed is NFKB1; the disease is neoplasm.